Novel Technologies News for October 2019

Novel Technologies News Archive

New laboratory products in the limelight at Lab Innovations 2019 New laboratory products in the limelight at Lab Innovations 2019

London, UK – 16th October 2019 – Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, will see a number of new product introductions at Birmingham’s NEC, 30 & 31 October. Many of the award-winning shows’ exhibitors will be launching or highlighting their very latest laboratory innovations, services and solutions - from general lab equipment and informatics, to larger scale industrial and cleanroom technology. 10% bigger than last year, the event will feature 160+ lab suppliers both large and small, exhibiting hundreds of cutting-edge products, including leading brands and novel solutions for all areas of the lab environment

This week in Drug Discovery Today This week in Drug Discovery Today

As a service from Drug Discovery Today, we are beginning to highlight those papers that have been published as "Articles in Press" either as corrected or uncorrected proofs in the preceding week. We hope that they are of interest to you. The articles are citable via their doi.

Life-like “on-a-chip” model of human perfused blood vessels offers new solutions for toxicity testing, drug discovery, and precision medicine Life-like “on-a-chip” model of human perfused blood vessels offers new solutions for toxicity testing, drug discovery, and precision medicine

Neuchâtel, Switzerland, 01 October 2019 – A unique, three-dimensional model of human blood vessels has been demonstrated to accurately assess a key stage in the development of inflammation and vascular disorders such as atherosclerosis. The microvessel-on-a-chip, jointly developed and optimized by Philip Morris International (PMI) and organ-on-a-chip specialists MIMETAS (Leiden, The Netherlands), can be used under flow to measure the attachment of immune cells to the blood vessel wall—an important feature of early onset atherogenesis—as well as gain unique mechanistic insights through analysis of transcriptomic profiles. In addition, the model has been shown to be effective in applications such as the toxicological assessment of consumer products.